GlaxoSmithKline Consumer Health Care New Zealand Limited
GlaxoSmithKline Consumer Health Care New Zealand Limited has been warned for likely breaching section 10 and 13(e) of the Fair Trading Act for misrepresentation as to the nature or characteristics of goods or their suitability for a purpose relating to Voltaren and Panadol products.
PartiesGlaxoSmithKline Consumer Health Care New Zealand Limited
